Keyphrases
Myasthenia Gravis
100%
Pyridostigmine
100%
Bradycardia
75%
Hyoscyamine
50%
Long-term Treatment
25%
Methylprednisolone
25%
Pharmacological Agents
25%
Right-sided
25%
Pharmacological Therapy
25%
Female Patients
25%
Potential Side Effects
25%
Atropine
25%
Levo
25%
Family History
25%
Dysphagia
25%
70 Years Old
25%
Asystole
25%
Permanent Pacemaker
25%
Covalent Inhibitor
25%
IMPDH
25%
Diplopia
25%
Conduction System
25%
Dysarthria
25%
Dual-chamber Pacemaker
25%
Facial muscles
25%
Ocular Movements
25%
Bradyarrhythmia
25%
Parasympathomimetics
25%
Medicine and Dentistry
Myasthenia gravis
100%
Pyridostigmine
100%
Hyoscyamine
50%
Weakness
25%
Methylprednisolone
25%
Heart Arrest
25%
Family History
25%
Plummer-Vinson Syndrome
25%
Eye Movement
25%
Permanent Pacemaker
25%
Diplopia
25%
Parasympathomimetic Drug
25%
Dysarthria
25%
Facial Muscle
25%
Inosinate Dehydrogenase
25%
Side Effect
25%
Pacemaker
25%
Pharmacology, Toxicology and Pharmaceutical Science
Myasthenia gravis
100%
Pyridostigmine
100%
Hyoscyamine
50%
Cholinergic Receptor Stimulating Agent
25%
Methylprednisolone
25%
Heart Arrest
25%
Weakness
25%
Inosinate Dehydrogenase
25%
Dysphagia
25%
Diplopia
25%
Dysarthria
25%
Side Effect
25%
Biochemistry, Genetics and Molecular Biology
Hyoscyamine
100%
Solution and Solubility
50%
Oxidoreductase
50%
Dehydrogenase
50%
Inosinic Acid
50%
Asystole
50%
Methylprednisolone
50%
Eye Movement
50%